In Reply We thank Drs Gore and Cohn for their interest in our article1 and thoughtful comments. We agree that ongoing research is needed; however, we would like to point out several issues. First, many parabens are, in fact, not banned in the European Union. The European Union has banned 5 longer-chain parabens not because of evidence that they are unsafe, but rather because “no information was submitted by industry for the safety evaluation [of these compounds].”2 All of the most commonly used parabens, including methylparaben, ethylparaben, propylparaben, and butylparaben, along with many others, are considered safe and legal for use as preservatives in Europe.2 Although many researchers in the clean beauty movement have expressed concerns about the potential for endocrine disruption by parabens, studies in rats and yeast cells have shown parabens to be thousands to millions of times weaker than estradiol, an endogenous sex hormone.3 Given that women are exposed to much more potent natural estrogens, along with estrogens in oral contraceptive pills and even phytoestrogens in food, the extremely weak estrogenicity of parabens is unlikely to be meaningful. The Cosmetic Ingredient Review has done an extensive investigation of the scientific literature on paraben safety and has concluded that parabens are safe in personal care products. The US Food and Drug Administration has also concluded that parabens are safe when used in personal care products.4
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Rubin CB, Brod BA. Endocrine-Disrupting Chemicals in Cosmetics—Reply. JAMA Dermatol. 2020;156(5):604. doi:10.1001/jamadermatol.2019.4661
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: